Do rapid emotional thermometers correlate with multidimensional validated structured questionnaires in low-risk prostate cancer?

被引:1
|
作者
Laranja, Walker Wendell [1 ,2 ]
Pereira, Thairo Alves [1 ,2 ]
Guimaraes, Paulo Vitor Barreto [1 ,2 ]
Tobias-Machado, Marcos [1 ,2 ]
Leandro-Merhi, Vania Aparecida [1 ,2 ]
de Aquino, Jose Luis Braga [1 ,2 ]
Reis, Leonardo Oliveira [1 ,2 ]
机构
[1] Univ Estadual Campinas, UroScience, Campinas, SP, Brazil
[2] Pontifical Catholic Univ Campinas, Campinas, SP, Brazil
关键词
Prostate cancer; Emotional; Suffering; Thermometer; Questionnaire; HRQoL; DISTRESS THERMOMETER; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; QUALITY; SATISFACTION; DEPRESSION; BARRIERS; VERSION; BURDEN; INDEX;
D O I
10.1007/s11255-020-02399-w
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose To promptly identify mental suffering in low-risk prostate cancer (LRPC) patients, vulnerable to over- and undertreatment, we evaluated the correlation of rapid emotional thermometers (ET) with multidimensional validated structured questionnaires. Methods At diagnosis, consecutive LRPC patients underwent five ET domains: emotional suffering, anxiety, depression (DT), revolt and need for help and multidimensional questionnaires: beck anxiety inventory (BAI), beck depression inventory (BDI), beck hopelessness scale, SF36 (physical functioning PF, role limitations due to physical health RP, bodily pain BP, general health perceptions GH, vitality VT, social functioning SF, role limitations due to emotional problems RE and general mental health MH), international index of erectile function and international prostate symptom score (IPSS). Results Among 30 included patients, mean age 67.4 y (52-74), 20 days after the diagnosis (15-30), mean time to obtain ET 27 s (15-57) and all questionnaires 36.7 min (31-49), ETs showed moderate/strong Spearman correlation among themselves. DT domain displayed the best correlation to most of the multidimensional validated structured questionnaires: moderate to BDI, SF-36 (PF, GH, VT, SF, RE, MH) and IPSS and strong to BAI. Conclusion DT revealed the best correlation to validated structured questionnaires of diverse dimensions with clear potential for quick screening of patients with psychological suffering and in need of further evaluation and support.
引用
收藏
页码:1073 / 1078
页数:6
相关论文
共 50 条
  • [31] What is the molecular pathology of low-risk prostate cancer?
    Hemamali Samaratunga
    Jonathan I. Epstein
    World Journal of Urology, 2008, 26 : 431 - 436
  • [32] Racial Disparities in Low-Risk Prostate Cancer Reply
    Mahal, Brandon A.
    Huang, Franklin W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (17): : 1727 - 1728
  • [33] mTOR inhibitors for treatment of low-risk prostate cancer
    Liss, Michael A.
    Rickborn, Lanette
    DiGiovanni, John
    Bacich, Dean
    DeGraffenried, Linda A.
    Parihar, Manish
    Thompson, Ian M.
    Sharp, Zelton Dave
    MEDICAL HYPOTHESES, 2018, 117 : 63 - 68
  • [34] Active surveillance preferred for low-risk prostate cancer
    Bagcchi, Sanjeet
    LANCET ONCOLOGY, 2015, 16 (08): : E384 - E384
  • [35] Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
    Augustin, Herbert
    Mayerhofer, Katrin
    Seles, Maximilian
    Pummer, Karl
    UROLOGIA INTERNATIONALIS, 2015, 95 (02) : 125 - 131
  • [36] What is the molecular pathology of low-risk prostate cancer?
    Samaratunga, Hemamali
    Epstein, Jonathan I.
    WORLD JOURNAL OF UROLOGY, 2008, 26 (05) : 431 - 436
  • [37] Chemical Castration and Survival in Low-risk Prostate Cancer
    van der Poel, Henk G.
    EUROPEAN UROLOGY, 2009, 56 (04) : 617 - 618
  • [38] Overtreatment of low-risk prostate cancer patients in the US
    Nature Clinical Practice Urology, 2006, 3 (12): : 631 - 631
  • [39] Focal Therapy for Low-Risk Prostate Cancer Opinion: No
    Sugano, Dordaneh
    Abreu, Andre Luis
    Cacciamani, Giovanni E.
    Gill, Inderbir S.
    Lebastchi, Amir H.
    JOURNAL OF ENDOUROLOGY, 2021, 35 (09) : 1284 - 1287
  • [40] THE DIVERSE GENOMIC LANDSCAPE OF LOW-RISK PROSTATE CANCER
    Cooperberg, Matthew R.
    Erho, Nicholas
    Chan, June M.
    Feng, Felix Y.
    Cowan, Janet E.
    Ong, Kaye
    Alshalalfa, Mohammed
    Kolisnik, Tyler
    Margrave, Jennifer
    Aranes, Maria
    du Plessis, Marguerite
    Buerki, Christine
    Zhao, Shuang G.
    Tenggara, Imelda
    Davicioni, Elai
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E912 - E912